Foundation Year Pharmacy – Clinical Practice Test

In COPD acute bacterial exacerbations, antibiotics are chosen to reliably cover the common respiratory pathogens (Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae) while avoiding beta-lactams in penicillin-allergic patients. Doxycycline fits this need because it has good activity against these typical pathogens and also covers atypicals, with excellent lung penetration and a favorable safety profile. It provides effective outpatient first-line therapy without using a beta-lactam, which is important for someone with a penicillin allergy. Other options either rely on beta-lactams (not suitable here) or involve broader-spectrum agents with more potential for resistance or adverse effects, making doxycycline the most appropriate first-line choice in this scenario.